National Cancer Center, Korea: Carcinoma trials

The registry lists 15 Carcinoma studies with National Cancer Center, Korea as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 8Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Active Surveillance for Low-risk Papillary Thyroid CarcinomaEnrolling by invitationNCT06261190
• Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary CancersRecruitingNCT06135896Phase 2
• Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCCCompletedNCT04611165Phase 2
• The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical RecurrenceStatus unknownNCT03062059Phase 2
• Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular CarcinomaCompletedNCT02395523Not applicable
• Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCCCompletedNCT01963429Not applicable
• A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCCCompletedNCT01829035Phase 3
• Hypofractionated Proton Beam Radiotherapy for Hepatocellular CarcinomaCompletedNCT01643824Not applicable
• Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic CarcinomaCompletedNCT01593475Phase 2
• Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian CancerCompletedNCT01538498
• Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic CarcinomaTerminatedNCT01333124Phase 2
• Study of External Beam Radiotherapy to Thyroid CarcinomaCompletedNCT01173289Phase 2
• Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)Status unknownNCT01027676Phase 1/2
• Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)CompletedNCT00919009Phase 2
• Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular CarcinomaCompletedNCT00662246Phase 1